Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 579-583

  Cosulich, Sabina ^a   James, Neil ^a   Roberts, Ruth ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; NAFENOPIN; PALMITOYL COENZYME A; PEROXISOME PROLIFERATOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HEPATOMEGALY; LIVER CARCINOGENESIS; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; RAT;

EID: 0034006961     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.579     Document Type: Article

References (37)

1. James, N., Gill, J., Brindle, R., Woodyatt, N., Macdonald, N., Rolfe, M., Holden, P., Tugwood, J. and Roberts, R. (1998) PPAR-alpha mediated responses and their importance in carcinogenesis. Toxicol. Lett., 102-103, 91-96.
2. Christensen, J.G., Gonzales, A.J., Cattley, R.C. and Goldsworthy, T.L. (1998) Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ., 9, 815-825.
3. Hasmall, S.C. and Roberts, R.A. (1999) The perturbation of apoptosis and mitosis by drugs and xenobiotics. Pharmacol. Ther., 82, 63-70.
4. Roberts, R.A. and Kimber, I. (1999) Cytokines in non-genotoxic hepatocarcinogenesis Carcinogenesis, 20, 1397-1401.
5. Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
6. Peters, J., Cattley, R. and Gonzalez, F. (1997) Role of PPAR-alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis, 18, 2029-2033.
7. Rolfe, M., James, N. and Roberts, R. (1997) Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis, 18, 2277-2280.
8. Bojes, H., Germolec, D., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M. and Thurman, R. (1997) Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis, 18, 669-674.
9. Bradham, C.A., Plümpe, J., Manns, M.P., Brenner, D.A. and Trautwein, C. (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Phys., 275, G387-G392.
10. Vandenabeele, P., Declercq, W., Beyaert, R. and Fiers, W. (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol., 5, 392-399.
11. Boulton, R., Woodman, A., Calnan, D., Seiden, C., Tam, F. and Hodgson, H. (1997) Nonparenchymal cells from regenerating rat liver generate interleukin-1 alpha and -1 beta: a mechanism of negative regulation of hepatocyte proliferation. Hepatology, 26, 49-58.
12. Gregory, S., Wing, E., Danowski, K., van Rooijen, N., Dyer, K. and Tweardy, D. (1998) IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. J. Immunol., 160, 6056-6061.
13. Rose, M., Germolec, D., Schoonhoven, R. and Thurman, R. (1997) Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis, 18, 1453-1456.
14. Rose, M.L., Rivera, C.A., Bradford, B.U., Graves, L.M., Cattley, R.C., Schoonhoven, R., Swenberg, J.A. and Thurman, R.G. (1999) Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Carcinogenesis, 20, 27-33.
15. Schaeffer, M.J. (1999) Mitogen-activated protein kinases:specific messages from ubiquitous messengers. Mol. Cell. Biol., 19, 2435-2444.
16. Robinson, M.J. and Cobb, M.H. (1997) Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol., 9, 180-186.
17. Lewis, T.S., Shapiro, P.S. and Ahn, N.G. (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res., 74, 49-139.
18. Raingeaud, J., Gupta, S., Rogers, J.S., Dickens, M., Han, J., Ulevitch, R.J. and Davis, R.J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem., 270, 7420-7426.
19. Mendelson, K., Contois, L., Tevosian, S., Davis, R. and Paulson, K. (1996) Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl Acad. Sci. USA, 93, 12908-12913.
20. Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J.C., Haegeman, G., Cohen, P. and Fiers, W. (1996) The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J., 15, 1914-1923.
21. Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M.L., Fiers, W. and Haegeman, G. (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem., 273, 3285-3290.
22. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. and Saltiel, A.R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494.
23. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R. and Lee, J.C. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett., 364, 229-233.
24. Seglen, P.O. (1973) Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp. Cell Res., 82, 391-398.
25. James, N. and Roberts, R. (1996) Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis, 17, 1623-1632.
26. Mitchell, A.M., Bridges, J.W. and Elcombe, C.R. (1984) Factors influencing peroxisome proliferation in cultured rat hepatocytes. Arch. Toxicol., 55, 239-246.
27. Swanton, E., Savory, P., Cosulich, S., Clarke, P. and Woodman, P. (1999) Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene, 18, 1781-1787.
28. Manthey, C.L., Wang, S.W., Kinney, S.D. and Yao, Z. (1998) SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leukocyte Biol., 64, 409-417.
29. Rokos, C. and Ledwith, B. (1997) Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J. Biol. Chem., 272, 13452-13457.
30. Chevalier, S., Macdonald, N. and Roberts, R.A. (1999) Induction of DNA replication by peroxisome proliferators is independent of both tumour necrosis factor a priming and EGF receptor tyrosine kinase activity. J. Cell Sci., 112, 4785-4791.
31. Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H. and Gonzalez, F.J. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol., 15, 3012-3022.
32. Shalev, A., Siegrist-Kaiser, C.A., Yen, P.M., Wahli, W., Burger, A.G., Chin, W.W. and Meier, C.A. (1996) The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology, 137, 4499-4502.
33. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A., Wahli, W., Meier, C. and Desvergne, B. (1997) DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem., 272, 25252-25259.
34. Camp, H. and Tafuri, S. (1997) Regulation of PPAR gamma activity by MAP kinase. J. Biol. Chem., 272, 10811-10816.
35. Griswold, D.E., Hillegass, L.M., O'Leary-Bartus, J., Lee, J.C., Laydon, J.T. and Torphy, T.J. (1996) Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo. J. Immunol. Methods, 195, 1-5.
36. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl Acad. Sci. USA, 92, 7080-7084.
37. Uchida, K., Shiraishi, M., Naito, Y., Torii, Y., Nakamura, Y. and Osawa, T. (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem., 274, 2234-2242.